Initial high-efficacy disease-modifying therapy in multiple sclerosis: A nationwide cohort study

Mathias Due Buron, Thor Ameri Chalmer, Finn Sellebjerg, Ismael Barzinji, Jeppe Romme Christensen, Mette Kirstine Christensen, Victoria Hansen, Zsolt Illes, Henrik Boye Jensen, Matthias Kant, Viktoria Papp, Thor Petersen, Peter Vestergaard Rasmussen, Jakob Schäfer, Ásta Theódórsdóttir, Arkadiusz Weglewski, Per Soelberg Sorensen, Melinda Magyari